Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovaBay Pharmaceuticals (NBY) Shares Outstanding (2016 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Shares Outstanding for 15 consecutive years, with $482000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding fell 90.13% to $482000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $482000.0, a 90.13% decrease, with the full-year FY2024 number at $4.9 million, up 69685.71% from a year prior.
  • Shares Outstanding was $2.0 million for Q3 2025 at NovaBay Pharmaceuticals, up from $1000.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.8 million in Q1 2021 to a low of $1000.0 in Q2 2024.
  • A 5-year average of $2.9 million and a median of $13000.0 in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: surged 69685.71% in 2024, then tumbled 99.89% in 2025.
  • NovaBay Pharmaceuticals' Shares Outstanding stood at $14000.0 in 2021, then skyrocketed by 314.29% to $58000.0 in 2022, then crashed by 87.93% to $7000.0 in 2023, then soared by 69685.71% to $4.9 million in 2024, then tumbled by 90.13% to $482000.0 in 2025.
  • Per Business Quant, the three most recent readings for NBY's Shares Outstanding are $482000.0 (Q3 2025), $5.8 million (Q2 2025), and $1000.0 (Q1 2025).